Virtus ETF Advisers LLC Mei Pharma, Inc. Transaction History

Virtus ETF Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.65 $27,137 - $41,999	-64,614 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.54 - $2.74 $2,066 - $10,485	-3,827 Reduced 5.59%	64,614 $39,000
Q4 2021 Feb 14, 2022	BUY	$2.33 - $3.37 $8,439 - $12,206	3,622 Added 5.59%	68,441 $183,000
Q3 2021 Nov 15, 2021	SELL	$2.52 - $2.99 $8,512 - $10,100	-3,378 Reduced 4.95%	64,819 $179,000
Q2 2021 Aug 10, 2021	SELL	$2.6 - $3.65 $92,367 - $129,669	-35,526 Reduced 34.25%	68,197 $194,000
Q1 2021 May 17, 2021	BUY	$2.73 - $4.5 $4,965 - $8,185	1,819 Added 1.79%	103,723 $356,000
Q4 2020 Feb 12, 2021	BUY	$2.6 - $3.32 $35,331 - $45,115	13,589 Added 15.39%	101,904 $269,000
Q3 2020 Nov 13, 2020	SELL	$2.46 - $4.27 $29,633 - $51,436	-12,046 Reduced 12.0%	88,315 $276,000
Q2 2020 Aug 05, 2020	BUY	$1.45 - $4.3 $145,523 - $431,552	100,361 New	100,361 $414,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $318M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.